EN | 中文
Sinobiopharma (Dong Ying Pharmaceuticals)

Sinobiopharma (Dong Ying Pharmaceuticals), selected into the top 2 of Zero2IPOs 2012 Venture 50, is a clear leader in its market segments, outperforming and outcompeting local and MNC drug makers. Through high technical-barrier innovation, Sinobiopharma has re-engineered its improved (me-better) generic drug products to make them relevant and cost-effective in China unique landscapes of market and infrastructure.Sinobiopharma has enjoyed dramatic sales and profit growth over the last several years.